STOCK TITAN
  1. Home
  2. ZGNX

Zogenix (ZGNX) Stock Price, News & Analysis

ZGNX NASDAQ
Published by Stock Titan Data refreshed

What Changed

Price Move History

Daily moves over 5%
15 254 sessions, March 4, 2021 to March 4, 2022
Largest daily move
+65.7% close of January 19, 2022
1-year change
+31.7% closing prices, March 4, 2021 to March 4, 2022
1-month change
+2.3% closing prices, February 4, 2022 to March 4, 2022

Company Description

ZGNX gained 31.7% in the 12 months to March 4, 2022. The last closing price was $26.68.

This page collects what Stock Titan holds for ZGNX, including price data and latest news.

Stock Performance

Chart
$26.68
No recent trading
Last close: March 4, 2022
+31.7%
1 year to March 4, 2022
-
Market Cap
56.0M
Shares outstanding

Zogenix (ZGNX) closed at $26.68 on March 4, 2022. In the 12 months to March 4, 2022, the price gained 31.7%.

See what a $1,000 investment in ZGNX would be worth today

Average down calculator for ZGNX

ZGNX Metrics & Rankings

March 2022
+1.6%
—
2022
+64.2%
—

Price returns through March 4, 2022. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

View All
—

UCB Completes Acquisition of Zogenix, Inc.

acquisition
+1.60%

Zogenix To Present New Long-term Data on FINTEPLA® (fenfluramine) in Lennox-Gastaut Syndrome (LGS) at AAN 2022

conferences
+0.38%

Immunicom Appoints Jennifer Haldeman as Vice President of Commercial Operations

management
+0.61%

Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results

earnings
+0.38%

Zogenix Supports New No-Cost Genetic Testing Program with United Mitochondrial Disease Foundation to Improve Diagnosis of Mitochondrial Diseases

0.00%

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Zogenix, Inc. (Nasdaq - ZGNX), Social Capital Suvretta Holdings Corp. III (Nasdaq - DNAC), Viveon Health Acquisition Corp. (NYSE American - VHAQ)

acquisition
+65.73%

UCB to acquire Zogenix

acquisition
+2.28%

Zogenix Submits New Drug Application for FINTEPLA® (Fenfluramine) in Japan for the Treatment of Epileptic Seizures Associated with Dravet Syndrome

+6.80%

Zogenix Submits Type II Variation Application to the European Medicines Agency (EMA) to Expand the Use of FINTEPLA® (Fenfluramine) for the Treatment of Seizures Associated with Lennox-Gastaut Syndrome

+4.41%

Zogenix Reports Granting of Inducement Awards

Zogenix has 10 recent news articles. Of the recent coverage, 8 articles coincided with positive price movement and 0 with negative movement. Key topics include acquisition, conferences, management, earnings. View all ZGNX news →

SEC Filings

No SEC filings available for ZGNX.

Frequently Asked Questions

What is the current quoted price of Zogenix (ZGNX)?

Zogenix (ZGNX) has no recent trading. Its last close was $26.68 on March 4, 2022.